Arthur Hull Hayes
Keine laufenden Positionen mehr
Profil
Arthur Hull Hayes is the founder of Mediscience Associates, Inc. founded in 1991.
He was the President & Chief Operating Officer of Mediscience Associates, Inc. from 1991 to 2005.
Dr. Hayes's former jobs include President & Chief Executive Officer of EMD Pharmaceuticals, Inc. from 1986 to 1990, Director of Celgene Corp.
from 1995 to 2010, Director of Tapestry Pharmaceuticals, Inc. from 1996 to 2007, Director of Myriad Genetics, Inc. from 1992 to 2008, Director of QuantRx Biomedical Corp.
from 2006 to 2010, Clinical Professor-Medicine & Pharmacology at The Pennsylvania State University from 1981 to 2004, Commissioner at US Food & Drug Administration from 1981 to 1983, and Director & Founder of Tapestry, Inc. (California).
Ehemalige bekannte Positionen von Arthur Hull Hayes
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Direktor/Vorstandsmitglied | 11.02.2010 |
| QUANTRX BIOMEDICAL CORPORATION | Direktor/Vorstandsmitglied | 11.02.2010 |
| Tapestry, Inc. (California) | Direktor/Vorstandsmitglied | 11.02.2010 |
| Mediscience Associates, Inc. | Gründer | 11.02.2010 |
| MYRIAD GENETICS, INC. | Direktor/Vorstandsmitglied | 29.02.2008 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MYRIAD GENETICS, INC. | Health Technology |
| QUANTRX BIOMEDICAL CORPORATION | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Tapestry Pharmaceuticals, Inc.
 Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
| Mediscience Associates, Inc. | |
| Tapestry, Inc. (California) | |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Health Technology |
